There is a negative cash flow of $4.5m. Most of this is due to expenditure of over $20m against the $15.75m that was forecast in the march quarterly.
The AGM presentation gave a very detailed forecast for production throughout the year. had this been met they would have produced just over 1000 tonnes of contained Ni. The cave in should have knocked this back to about 950 as the concentrator plant was only shut down for 4 days. For them to produce significantly less than Q1 is astounding.
Cash and Debtors decreased by nearly $10m - this is not the whole picture as creditors and stocks may have changed but $10m vs $4.5m negative cash flow needs explaining.
it is never a good sign when the CFO goes when bad news like this in announced.
The quarterly report raises some serious questions. Albidon Action will be asking them and we will be expecting answers.
- Forums
- ASX - By Stock
- Ann: June Quarterly Report and Appendix 5B
ALB
albion resources limited
Add to My Watchlist
0.00%
!
5.7¢

There is a negative cash flow of $4.5m. Most of this is due to...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
5.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.520M |
Open | High | Low | Value | Volume |
5.7¢ | 5.7¢ | 5.4¢ | $21.73K | 384.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 16805 | 5.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.6¢ | 90000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 16805 | 0.054 |
1 | 49999 | 0.053 |
1 | 30000 | 0.051 |
2 | 145000 | 0.049 |
1 | 22222 | 0.045 |
Price($) | Vol. | No. |
---|---|---|
0.056 | 90000 | 1 |
0.057 | 121825 | 2 |
0.059 | 50001 | 1 |
0.065 | 12500 | 1 |
0.070 | 200000 | 1 |
Last trade - 15.02pm 27/06/2025 (20 minute delay) ? |
Featured News
ALB (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online